DBS Puncher

Efficient punching of sample disks

OVERVIEW

DBS Puncher

The DBS Puncher is a versatile, automated instrument for punching dried blood spot samples into 96-well microtitration plates. The instrument supports a wide range of assays employing blood spots as well as other samples dried on filter paper. The DBS Puncher is well-suited for preparing plates for feeding into an automatic immunoassay system.

Instrument

Punching DBS

IMG_1388_valkoinen_tausta

Efficient punching for your laboratory

The DBS Puncher is available as a standalone unit, or configured with a barcode reader and external PC with DBS Workstation software for identification of the patient sample. For process and data management, connection to an external PC also allows the transfer of worklists.
There are four selection buttons for instrument control, and the instrument is operated by hand or by foot-switch. Ease of use is enhanced by a clear double line display, and by illumination of the area being punched.

Laboratory Management at your finger tips

SOFTWARE
Analyze at scale
SOFTWARE

Specimen Gate® software

Newborn screening software that provides control and monitoring tools for the entire screening process.

Specimen Gate software is designed to simplify the data collection and workflow processes
involved with receiving specimens, screening for abnormalities, managing patient information, generating specimen reports, and following up abnormal and unsatisfactory specimens.

Laboratory Equipment no matter your size or sophistication

More Newborn Screening Instruments

GSP® Instrument

GSP® Instrument

Automated platform for screening of NBS disorders, the GSP® Newborn screening system offers outstanding screening accuracy and reliability, coupled with high efficiency and user-friendliness.
AutoDELFIA® immunoassay system

AutoDELFIA® immunoassay system

AutoDELFIA® immunoassay system for prenatal & neonatal screening with fully automated batch-loading
VICTOR2™ D fluorometer

VICTOR2™ D fluorometer

Fluorometer designed for clinical use with all PerkinElmer diagnostic and screening assays based on either time-resolved fluorescence or prompt fluorescence.
QSight® MD Screening Systems

QSight® MD Screening Systems

The QSight® MD mass spectrometry screening systems are designed for routine high throughput quantitation. They offer expanded screening for a variety of inborn errors of metabolism with a wide analyte panel, and access to Tier 2 chromatography (QSight® 225 MD UHPLC only).
EONIS™ System

EONIS™ System

A complete system for SMA, SCID & XLA screening, from sample to results. The design of the EONIS assay and system enable automation without compromising the sample traceability from punch to result.
Migele™ Gel Electrophoresis Unit

Migele™ Gel Electrophoresis Unit

Migele™ Gel Electrophoresis Unit works with the RESOLVE™ hemoglobin kit to detect hemoglobinopathies in newborns and adults, including sickle cell disease and other hemoglobin variants and thalassemias.
PerkinElmer 226 Sample collection device

PerkinElmer 226 Sample collection device

The PerkinElmer 226 Sample Collection Device offers a minimally invasive technique for Dried Blood Sample (DBS) collection
Panthera Puncher™ 9 Instrument

Panthera Puncher™ 9 Instrument

Panthera Puncher™ 9 is the new generation dried sample punching device for automatically punching dry blood spot samples into microtitration plates.
Articles & Resources

Articles & Resources

First SMA baby identified with our screening solutions in Australia
Newborn
26 Apr 2021

First SMA baby identified with our screening solutions in Australia

A newborn baby has been identified as having SMA (spinal muscular atrophy) in Westmead Children’s Hospital in Australia, using a 4-plex SMA, SCID and XLA laboratory developed test
First years of experience on LSD screening in Italy, Padova
Newborn
22 Apr 2021

First years of experience on LSD screening in Italy, Padova

The increasing availability of treatments and the importance of early intervention have stimulated newborn screening (NBS) for lysosomal storage diseases (LSDs). We present our experience screening newborns in North East Italy to identify neonates with Mucopolysaccharidosis type I (MPS I) and Pompe, Fabry, and Gaucher diseases.

Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.

 

GET IN TOUCH

Take the next step

Speak with a sales person

Talk to one of our product experts about the right solutions for you.

Contact us today

View more resources

Explore our articles and resources section for the latest information

Learn More

Read the lastest news

Sign up for our newsletter to find out about the latest news from PerkinElmer and the industry

Sign up

Sign Up for our Newsletter